These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 29343833
1. Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs. Ferruz N, Doerr S, Vanase-Frawley MA, Zou Y, Chen X, Marr ES, Nelson RT, Kormos BL, Wager TT, Hou X, Villalobos A, Sciabola S, De Fabritiis G. Sci Rep; 2018 Jan 17; 8(1):897. PubMed ID: 29343833 [Abstract] [Full Text] [Related]
2. Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism. Lane JR, Abramyan AM, Adhikari P, Keen AC, Lee KH, Sanchez J, Verma RK, Lim HD, Yano H, Javitch JA, Shi L. Elife; 2020 Jan 27; 9():. PubMed ID: 31985399 [Abstract] [Full Text] [Related]
3. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, Shi L, Newman AH, Javitch JA, Cherezov V, Stevens RC. Science; 2010 Nov 19; 330(6007):1091-5. PubMed ID: 21097933 [Abstract] [Full Text] [Related]
4. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs. Tarcsay A, Paragi G, Vass M, Jójárt B, Bogár F, Keserű GM. J Chem Inf Model; 2013 Nov 25; 53(11):2990-9. PubMed ID: 24116387 [Abstract] [Full Text] [Related]
5. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling. Coudrat T, Simms J, Christopoulos A, Wootten D, Sexton PM. PLoS Comput Biol; 2017 Nov 25; 13(11):e1005819. PubMed ID: 29131821 [Abstract] [Full Text] [Related]
6. Towards predictive docking at aminergic G-protein coupled receptors. Jakubík J, El-Fakahany EE, Doležal V. J Mol Model; 2015 Nov 25; 21(11):284. PubMed ID: 26453085 [Abstract] [Full Text] [Related]
7. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor. Chen H, Fu W, Wang Z, Wang X, Lei T, Zhu F, Li D, Chang S, Xu L, Hou T. ACS Chem Neurosci; 2019 Jan 16; 10(1):677-689. PubMed ID: 30265513 [Abstract] [Full Text] [Related]
8. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors. Bhunia SS, Saxena AK. Curr Top Med Chem; 2021 Jan 16; 21(4):269-294. PubMed ID: 32901584 [Abstract] [Full Text] [Related]
9. Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines. Zanatta G, Nunes G, Bezerra EM, da Costa RF, Martins A, Caetano EW, Freire VN, Gottfried C. ACS Chem Neurosci; 2014 Oct 15; 5(10):1041-54. PubMed ID: 25181639 [Abstract] [Full Text] [Related]
10. Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning. Ferraro M, Decherchi S, De Simone A, Recanatini M, Cavalli A, Bottegoni G. Eur J Med Chem; 2020 Feb 15; 188():111975. PubMed ID: 31940507 [Abstract] [Full Text] [Related]
11. How Do Molecular Dynamics Data Complement Static Structural Data of GPCRs. Torrens-Fontanals M, Stepniewski TM, Aranda-García D, Morales-Pastor A, Medel-Lacruz B, Selent J. Int J Mol Sci; 2020 Aug 18; 21(16):. PubMed ID: 32824756 [Abstract] [Full Text] [Related]
12. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors. Emtage AL, Mistry SN, Fischer PM, Kellam B, Laughton CA. J Biomol Struct Dyn; 2017 Sep 18; 35(12):2604-2619. PubMed ID: 27532213 [Abstract] [Full Text] [Related]
13. Critical analysis of the successes and failures of homology models of G protein-coupled receptors. Bhattacharya S, Lam AR, Li H, Balaraman G, Niesen MJ, Vaidehi N. Proteins; 2013 May 18; 81(5):729-39. PubMed ID: 23042299 [Abstract] [Full Text] [Related]
14. Progress in the structural prediction of G protein-coupled receptors: D3 receptor in complex with eticlopride. Obiol-Pardo C, López L, Pastor M, Selent J. Proteins; 2011 Jun 18; 79(6):1695-703. PubMed ID: 21491496 [Abstract] [Full Text] [Related]
16. Selectivity and activation of dopamine D3R from molecular dynamics. Feng Z, Hou T, Li Y. J Mol Model; 2012 Dec 18; 18(12):5051-63. PubMed ID: 22752545 [Abstract] [Full Text] [Related]
17. Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs). Reilly SW, Riad AA, Hsieh CJ, Sahlholm K, Jacome DA, Griffin S, Taylor M, Weng CC, Xu K, Kirschner N, Luedtke RR, Parry C, Malhotra S, Karanicolas J, Mach RH. J Med Chem; 2019 May 23; 62(10):5132-5147. PubMed ID: 31021617 [Abstract] [Full Text] [Related]
18. Synergistic Use of GPCR Modeling and SDM Experiments to Understand Ligand Binding. Potterton A, Heifetz A, Townsend-Nicholson A. Methods Mol Biol; 2018 May 23; 1705():335-343. PubMed ID: 29188570 [Abstract] [Full Text] [Related]
19. A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors. Michino M, Donthamsetti P, Beuming T, Banala A, Duan L, Roux T, Han Y, Trinquet E, Newman AH, Javitch JA, Shi L. Mol Pharmacol; 2013 Dec 23; 84(6):854-64. PubMed ID: 24061855 [Abstract] [Full Text] [Related]
20. Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation. Platania CB, Salomone S, Leggio GM, Drago F, Bucolo C. PLoS One; 2012 Dec 23; 7(9):e44316. PubMed ID: 22970199 [Abstract] [Full Text] [Related] Page: [Next] [New Search]